Wolters Kluwer is launching The Patient, a quarterly journal that will look at reimbursement issues from a patient perspective.
“We're trying to change the world from one that says ‘no' to medical innovation to one that says, ‘Well, what does the patient think?'” says editor John F. P. Bridges, PhD, of Johns Hopkins Bloomberg School of Public Health. Bridges says formularies, governments and others making decisions about drug access need to break out of the cost-effectiveness model as an exclusive means of determining the value of a medication. The title, intended to complement PharmacoEconomics, will launch in the fourth quarter.